Literature DB >> 15628872

Antisense recognition of the HER-2 mRNA: effects of phosphorothioate substitution and polyamines on DNA.RNA, RNA.RNA, and DNA.DNA duplex stability.

Sripriya Venkiteswaran1, Veena Vijayanathan, Akira Shirahata, Thresia Thomas, T J Thomas.   

Abstract

The HER-2 gene is overexpressed in a subset of breast, ovarian, lung, and pancreatic cancers. Antisense oligonucleotides suppress gene expression depending on the stability of the DNA.RNA hybrids formed at the target site. Polyamines, the cellular cations that interact with DNA and RNA, may influence hybrid stability in the cell. Therefore, we studied the ability of natural polyamines (putrescine, spermidine, and spermine) and a series of their structural analogues to stabilize DNA.RNA and RNA.RNA duplexes using melting temperature (T(m)) measurements and circular dichroism (CD) spectroscopy. Phosphodiester (PO) and phosphorothioate (PS) oligonucleotides (ODNs) (15 nucleotides, 5'-CTCCATGGTGCTCAC-3') targeted to the initiation codon region of the HER-2 mRNA, and complementary RNA and DNA ODNs, were used in this study. The relative order of thermal stability was as follows: RNA.RNA > PO-DNA.RNA > PO-DNA.PO-DNA > PS-DNA.RNA > PS-DNA.PO-DNA > PS-DNA.PS-DNA. The ability of polyamines to stabilize the duplexes improved with the cationicity of the polyamine, with hexamines being more effective than pentamines, which in turn were more effective than tetramines and triamines. However, chemical structural effects were clearly evident with isovalent homologues of spermidine and spermine. CD spectra showed B and A conformations, respectively, for the DNA and RNA helices. DNA.RNA hybrids adopted an intermediate structure between the B and A forms. These data help us to understand the role of endogenous polyamines in DNA.RNA hybrid stabilization, and provide information for designing novel polyamines to facilitate the use of antisense ODNs for controlling HER-2 gene expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15628872     DOI: 10.1021/bi0485272

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Improved delivery in cell culture of radiolabeled antisense DNAs by duplex formation.

Authors:  Xinrong Liu; Kayoko Nakamura; Yi Wang; Surong Zhang; Jiang He; Guozheng Liu; Shuping Dou; Atsushi Kubo; Mary Rusckowski; Donald Hnatowich
Journal:  Mol Imaging Biol       Date:  2006 Sep-Oct       Impact factor: 3.488

2.  Atomic detail investigation of the structure and dynamics of DNA.RNA hybrids: a molecular dynamics study.

Authors:  U Deva Priyakumar; Alexander D Mackerell
Journal:  J Phys Chem B       Date:  2008-01-16       Impact factor: 2.991

3.  Dystrophia myotonia: why focus on foci?

Authors:  R P Junghans
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

4.  Polyamine analogues bind human serum albumin.

Authors:  R Beauchemin; C N N'soukpoé-Kossi; T J Thomas; T Thomas; R Carpentier; H A Tajmir-Riahi
Journal:  Biomacromolecules       Date:  2007-09-22       Impact factor: 6.988

5.  DNAzyme-mediated recovery of small recombinant RNAs from a 5S rRNA-derived chimera expressed in Escherichia coli.

Authors:  Yamei Liu; Victor G Stepanov; Ulrich Strych; Richard C Willson; George W Jackson; George E Fox
Journal:  BMC Biotechnol       Date:  2010-12-06       Impact factor: 2.563

Review 6.  Endogenous polyamine function--the RNA perspective.

Authors:  Helen L Lightfoot; Jonathan Hall
Journal:  Nucleic Acids Res       Date:  2014-09-17       Impact factor: 16.971

7.  Non-Nucleosidic Analogues of Polyaminonucleosides and Their Influence on Thermodynamic Properties of Derived Oligonucleotides.

Authors:  Jolanta Brzezinska; Wojciech T Markiewicz
Journal:  Molecules       Date:  2015-07-13       Impact factor: 4.411

Review 8.  Modified Nucleic Acids: Expanding the Capabilities of Functional Oligonucleotides.

Authors:  Steven Ochoa; Valeria T Milam
Journal:  Molecules       Date:  2020-10-13       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.